Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

22

Revenue 2017

Januvia

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Januvia was produced by Merck & Co..

AZ's Onglyza may increase mortality, says FDA

AZ's Onglyza may increase mortality, says FDA of Merck &Co's TECOS cardiovascular outcomes trial, which involves its $6bn-a-year DPP-4 inhibitor Januvia (sitagliptin). ... If Januvia is given a clean bill of health it suggests there is no class effect for DPP-4 inhibitors on cardiovascular risk.

Takeda's once-weekly DPP-4 inhibitor cleared in first market

Takeda's once-weekly DPP-4 inhibitor cleared in first market At the moment Merck &Co's once-daily DPP-4 inhibitor Januvia (sitagliptin) is comfortably leading the market with sales of almost $4bn last year although sales have started to slide

Lilly and Boehringer claim first place for diabetes combination

Lilly and Boehringer claim first place for diabetes combination as well as Pfizer's ertugliflozin and Merck &Co's Januvia (sitagliptin).

Merck files once-weekly DPP-4 inhibitor in first market

Merck files once-weekly DPP-4 inhibitor in first market the summer which showed the drug was comparable to Merck's $4bn-a-year, once-daily DPP-4 inhibitor Januvia (sitagliptin) in controlling blood glucose levels in type 2 diabetes, with

Servier licenses device that could 'reshape' diabetes care

Servier licenses device that could 'reshape' diabetes care One of the studies is a head-to-head trial with Merck &Co's DPP-4 inhibitor Januvia (sitagliptin), while the other is a cardiovascular outcomes study.

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...